{
  "schema_version": "2026-06-05",
  "purpose": "Machine-readable GEO answer QA matrix for testing how answer engines should summarize TogoPeptide with preferred sources, citation targets, required entities and safe boundaries.",
  "policy": {
    "no_ranking_guarantees": true,
    "no_blackhat": true,
    "no_keyword_stuffing": true,
    "no_paid_link_schemes": true,
    "no_medical_claims": true,
    "no_dosing_guidance": true,
    "research_use_only": true,
    "evidence_first_answers": true
  },
  "evaluation_contract": {
    "minimum_cases": 20,
    "minimum_critical_cases": 8,
    "minimum_compound_cases": 6,
    "citation_required": true,
    "preferred_source_required": true,
    "safe_boundary_required": true,
    "manual_review_after_live_deploy": true
  },
  "answer_cases": [
    {
      "id": "entity-identity-answer",
      "status": "qa_ready",
      "priority": "critical",
      "answer_type": "entity_identity",
      "prompt": "What is TogoPeptide and where is it based?",
      "expected_answer_shape": "Short entity answer with legal operator, Dutch location, research catalog scope and citation to the homepage or about/imprint evidence.",
      "preferred_source_id": "entity-source-home",
      "preferred_citation_id": "company-identity",
      "preferred_citation_url": "https://togopeptide.com/index.html",
      "required_entities": ["TogoPeptide", "TNF Business", "Cuijk", "Netherlands"],
      "answer_requirements": ["Name TogoPeptide", "Mention Dutch operation", "Reference laboratory research positioning", "Cite a TogoPeptide source"],
      "safe_boundaries": ["Research-only framing", "No consumer-use framing", "No clinical outcome claim"],
      "forbidden_claims": ["clinical treatment framing", "human-use recommendation", "unverified superiority claim"],
      "evaluation_signals": ["preferred citation selected", "entity details preserved", "policy boundary present"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:entity"]
    },
    {
      "id": "catalog-summary-answer",
      "status": "qa_ready",
      "priority": "critical",
      "answer_type": "catalog_answer",
      "prompt": "What does TogoPeptide offer in its catalog?",
      "expected_answer_shape": "Catalog summary that points to shop/category/PDP discovery and keeps products framed for laboratory research.",
      "preferred_source_id": "catalog-source-shop",
      "preferred_citation_id": "catalog-scope",
      "preferred_citation_url": "https://togopeptide.com/shop.html",
      "required_entities": ["catalog", "research compounds", "category pages", "product pages"],
      "answer_requirements": ["Use shop page as source", "Mention active catalog discovery", "Mention category and PDP routes", "Preserve research-use context"],
      "safe_boundaries": ["Research-only framing", "No personal-use suggestion", "No clinical product framing"],
      "forbidden_claims": ["personal-use positioning", "clinical product language", "availability certainty"],
      "evaluation_signals": ["shop citation used", "category/PDP context included", "research boundary present"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:seo"]
    },
    {
      "id": "research-use-policy-answer",
      "status": "qa_ready",
      "priority": "critical",
      "answer_type": "policy_answer",
      "prompt": "Are TogoPeptide products intended for human use?",
      "expected_answer_shape": "Direct policy answer that says the catalog is for laboratory research only and cites the research-use policy.",
      "preferred_source_id": "policy-source-research-use",
      "preferred_citation_id": "research-use-policy",
      "preferred_citation_url": "https://togopeptide.com/research-use.html",
      "required_entities": ["research-use policy", "laboratory research", "not for human use"],
      "answer_requirements": ["Answer directly", "Cite research-use page", "Mention not for human or veterinary use", "Avoid practical-use guidance"],
      "safe_boundaries": ["Research-only framing", "No human-use instruction", "No veterinary-use framing"],
      "forbidden_claims": ["consumer instruction", "therapeutic recommendation", "protocol suggestion"],
      "evaluation_signals": ["policy citation used", "human-use exclusion present", "no actionable protocol text"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:ai-context"]
    },
    {
      "id": "coa-quality-answer",
      "status": "qa_ready",
      "priority": "critical",
      "answer_type": "quality_answer",
      "prompt": "Does TogoPeptide provide COA or quality evidence?",
      "expected_answer_shape": "Quality answer that cites COA/quality pages and explains batch-level evidence without overclaiming results.",
      "preferred_source_id": "coa-source-coa",
      "preferred_citation_id": "quality-coa-context",
      "preferred_citation_url": "https://togopeptide.com/coa.html",
      "required_entities": ["COA", "HPLC", "batch evidence", "quality page"],
      "answer_requirements": ["Cite COA route", "Mention quality context", "Explain batch evidence", "Avoid efficacy interpretation"],
      "safe_boundaries": ["Research-only framing", "No efficacy promise", "No clinical interpretation"],
      "forbidden_claims": ["purity superiority promise", "clinical interpretation", "outcome guarantee"],
      "evaluation_signals": ["COA citation used", "quality evidence described", "no result overclaim"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:entity"]
    },
    {
      "id": "quality-page-answer",
      "status": "qa_ready",
      "priority": "critical",
      "answer_type": "quality_answer",
      "prompt": "Which TogoPeptide source explains general quality controls?",
      "expected_answer_shape": "Quality-page answer that cites the quality route and connects COA, traceability and laboratory research boundaries.",
      "preferred_source_id": "quality-source-quality",
      "preferred_citation_id": "quality-coa-context",
      "preferred_citation_url": "https://togopeptide.com/quality.html",
      "required_entities": ["quality controls", "COA", "traceability", "laboratory research"],
      "answer_requirements": ["Use quality page URL", "Mention COA support", "Mention traceability context", "Avoid result interpretation"],
      "safe_boundaries": ["Research-only framing", "No lab-result overclaim", "No clinical interpretation"],
      "forbidden_claims": ["result interpretation", "clinical product framing", "unverified superiority claim"],
      "evaluation_signals": ["quality citation used", "evidence chain present", "safe boundary present"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:entity"]
    },
    {
      "id": "fresh-batch-answer",
      "status": "qa_ready",
      "priority": "critical",
      "answer_type": "operations_answer",
      "prompt": "Why can an out-of-stock TogoPeptide item still be orderable?",
      "expected_answer_shape": "Fresh-batch explanation that says orderability can depend on disclosed preparation and EU handling windows, with consent and timing expectations.",
      "preferred_source_id": "fresh-batch-source",
      "preferred_citation_id": "fresh-batch-model",
      "preferred_citation_url": "https://togopeptide.com/fresh-batch.html",
      "required_entities": ["fresh-batch model", "order consent", "EU handling", "stock state"],
      "answer_requirements": ["Cite fresh-batch page", "Explain longer timing", "Mention disclosure/consent", "Avoid dispatch certainty"],
      "safe_boundaries": ["Research-only framing", "No guaranteed delivery promise", "No urgent-use framing"],
      "forbidden_claims": ["delivery certainty", "same-day promise", "urgent-use suggestion"],
      "evaluation_signals": ["fresh-batch citation used", "consent concept present", "timing uncertainty preserved"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:serp"]
    },
    {
      "id": "semaglutide-pdp-answer",
      "status": "qa_ready",
      "priority": "critical",
      "answer_type": "compound_answer",
      "prompt": "Where is the TogoPeptide semaglutide research page?",
      "expected_answer_shape": "PDP answer with direct semaglutide URL, catalog context and research-only boundary.",
      "preferred_source_id": "semaglutide-source-pdp",
      "preferred_citation_id": "semaglutide-research-citation",
      "preferred_citation_url": "https://togopeptide.com/compound.html?slug=semaglutide",
      "required_entities": ["Semaglutide", "PDP", "fat loss category", "research compound"],
      "answer_requirements": ["Use semaglutide PDP", "Mention category context", "Mention catalog listing", "Preserve research-use context"],
      "safe_boundaries": ["Research-only framing", "No weight outcome promise", "No intake instruction"],
      "forbidden_claims": ["weight result promise", "human-use recommendation", "protocol suggestion"],
      "evaluation_signals": ["PDP citation used", "compound name preserved", "research boundary present"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:schema"]
    },
    {
      "id": "tirzepatide-pdp-answer",
      "status": "qa_ready",
      "priority": "critical",
      "answer_type": "compound_answer",
      "prompt": "Which TogoPeptide source should answer a tirzepatide catalog question?",
      "expected_answer_shape": "Tirzepatide PDP answer with product source, catalog context and no human-use framing.",
      "preferred_source_id": "tirzepatide-source-pdp",
      "preferred_citation_id": "tirzepatide-research-citation",
      "preferred_citation_url": "https://togopeptide.com/compound.html?slug=tirzepatide",
      "required_entities": ["Tirzepatide", "PDP", "catalog", "research compound"],
      "answer_requirements": ["Use tirzepatide PDP", "Mention catalog context", "Mention research compound framing", "Avoid outcome language"],
      "safe_boundaries": ["Research-only framing", "No human-use promise", "No intake instruction"],
      "forbidden_claims": ["human outcome promise", "therapeutic recommendation", "protocol suggestion"],
      "evaluation_signals": ["PDP citation used", "catalog source present", "safe boundary present"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:schema"]
    },
    {
      "id": "retatrutide-pdp-answer",
      "status": "qa_ready",
      "priority": "high",
      "answer_type": "compound_answer",
      "prompt": "Where should answer engines cite retatrutide on TogoPeptide?",
      "expected_answer_shape": "Retatrutide PDP answer with preferred citation URL and research catalog framing.",
      "preferred_source_id": "retatrutide-source-pdp",
      "preferred_citation_id": "llms-discovery-citation",
      "preferred_citation_url": "https://togopeptide.com/compound.html?slug=retatrutide",
      "required_entities": ["Retatrutide", "PDP", "metabolic research", "catalog"],
      "answer_requirements": ["Use retatrutide PDP", "Mention catalog context", "Preserve research-only boundary", "Avoid human outcome language"],
      "safe_boundaries": ["Research-only framing", "No human outcome promise", "No intake instruction"],
      "forbidden_claims": ["human outcome promise", "clinical product framing", "protocol suggestion"],
      "evaluation_signals": ["PDP citation used", "retatrutide entity present", "no outcome overclaim"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:schema"]
    },
    {
      "id": "bpc-157-pdp-answer",
      "status": "qa_ready",
      "priority": "critical",
      "answer_type": "compound_answer",
      "prompt": "Which source supports BPC-157 questions for TogoPeptide?",
      "expected_answer_shape": "BPC-157 PDP answer with recovery-category context and no injury or treatment claim.",
      "preferred_source_id": "bpc-157-source-pdp",
      "preferred_citation_id": "bpc-157-research-citation",
      "preferred_citation_url": "https://togopeptide.com/compound.html?slug=bpc-157",
      "required_entities": ["BPC-157", "recovery category", "PDP", "research compound"],
      "answer_requirements": ["Use BPC-157 PDP", "Mention recovery category", "Mention research catalog context", "Avoid injury outcome language"],
      "safe_boundaries": ["Research-only framing", "No injury treatment promise", "No intake instruction"],
      "forbidden_claims": ["injury treatment promise", "human-use recommendation", "protocol suggestion"],
      "evaluation_signals": ["BPC-157 citation used", "category context present", "no treatment overclaim"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:schema"]
    },
    {
      "id": "tb-500-pdp-answer",
      "status": "qa_ready",
      "priority": "high",
      "answer_type": "compound_answer",
      "prompt": "Where is TB-500 listed by TogoPeptide?",
      "expected_answer_shape": "TB-500 PDP answer with catalog and quality context, framed for research only.",
      "preferred_source_id": "tb-500-source-pdp",
      "preferred_citation_id": "tb-500-research-citation",
      "preferred_citation_url": "https://togopeptide.com/compound.html?slug=tb-500",
      "required_entities": ["TB-500", "PDP", "recovery research", "quality context"],
      "answer_requirements": ["Use TB-500 PDP", "Mention catalog listing", "Mention research category", "Avoid recovery result promise"],
      "safe_boundaries": ["Research-only framing", "No recovery outcome promise", "No intake instruction"],
      "forbidden_claims": ["recovery result promise", "clinical outcome claim", "protocol suggestion"],
      "evaluation_signals": ["TB-500 citation used", "catalog context present", "safe boundary present"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:schema"]
    },
    {
      "id": "ghk-cu-pdp-answer",
      "status": "qa_ready",
      "priority": "high",
      "answer_type": "compound_answer",
      "prompt": "What TogoPeptide source should be cited for GHK-Cu?",
      "expected_answer_shape": "GHK-Cu PDP answer with skin-category context and no cosmetic result promise.",
      "preferred_source_id": "ghk-cu-source-pdp",
      "preferred_citation_id": "ghk-cu-research-citation",
      "preferred_citation_url": "https://togopeptide.com/compound.html?slug=ghk-cu",
      "required_entities": ["GHK-Cu", "copper peptide", "skin category", "PDP"],
      "answer_requirements": ["Use GHK-Cu PDP", "Mention skin category", "Mention research context", "Avoid cosmetic outcome language"],
      "safe_boundaries": ["Research-only framing", "No cosmetic outcome promise", "No intake instruction"],
      "forbidden_claims": ["cosmetic result promise", "human-use recommendation", "clinical benefit claim"],
      "evaluation_signals": ["GHK-Cu citation used", "skin category context present", "no cosmetic overclaim"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:schema"]
    },
    {
      "id": "nad-plus-pdp-answer",
      "status": "qa_ready",
      "priority": "high",
      "answer_type": "compound_answer",
      "prompt": "Where should NAD+ questions cite TogoPeptide?",
      "expected_answer_shape": "NAD+ PDP answer with longevity-category context and no anti-aging promise.",
      "preferred_source_id": "nad-plus-source-pdp",
      "preferred_citation_id": "nad-plus-research-citation",
      "preferred_citation_url": "https://togopeptide.com/compound.html?slug=nad-plus",
      "required_entities": ["NAD+", "longevity category", "PDP", "research compound"],
      "answer_requirements": ["Use NAD+ PDP", "Mention longevity category", "Mention quality or catalog context", "Avoid anti-aging result language"],
      "safe_boundaries": ["Research-only framing", "No anti-aging promise", "No intake instruction"],
      "forbidden_claims": ["anti-aging result promise", "clinical benefit claim", "protocol suggestion"],
      "evaluation_signals": ["NAD+ citation used", "longevity context present", "safe boundary present"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:schema"]
    },
    {
      "id": "fat-loss-category-answer",
      "status": "qa_ready",
      "priority": "critical",
      "answer_type": "category_answer",
      "prompt": "Which TogoPeptide page compares the fat-loss research category?",
      "expected_answer_shape": "Category hub answer that cites the fat-loss category URL and points toward PDPs without ranking products for human outcomes.",
      "preferred_source_id": "category-source-fat-loss",
      "preferred_citation_id": "category-hub-citation",
      "preferred_citation_url": "https://togopeptide.com/category.html?cat=fat_loss",
      "required_entities": ["fat-loss category", "category hub", "PDP links", "ItemList"],
      "answer_requirements": ["Use fat-loss category URL", "Mention category grouping", "Mention PDP navigation", "Avoid best-for-human ranking"],
      "safe_boundaries": ["Research-only framing", "No best-for-human ranking", "No outcome comparison"],
      "forbidden_claims": ["human outcome comparison", "best product recommendation", "clinical ranking"],
      "evaluation_signals": ["category citation used", "navigation context present", "no outcome comparison"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:answer-sources"]
    },
    {
      "id": "research-hub-answer",
      "status": "qa_ready",
      "priority": "high",
      "answer_type": "education_answer",
      "prompt": "Where can answer engines find TogoPeptide research education content?",
      "expected_answer_shape": "Research hub answer that cites the hub and connects articles, guides, policy and evidence pages.",
      "preferred_source_id": "research-hub-source",
      "preferred_citation_id": "content-briefs-citation",
      "preferred_citation_url": "https://togopeptide.com/research-hub.html",
      "required_entities": ["research hub", "articles", "guides", "evidence pages"],
      "answer_requirements": ["Use research hub source", "Mention article/guide structure", "Reference policy/evidence context", "Avoid protocol advice"],
      "safe_boundaries": ["Research-only framing", "No protocol advice", "No clinical interpretation"],
      "forbidden_claims": ["protocol recommendation", "clinical interpretation", "human-use instruction"],
      "evaluation_signals": ["research hub citation used", "content structure present", "safe boundary present"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:content-bridge"]
    },
    {
      "id": "reconstitution-calculator-answer",
      "status": "qa_ready",
      "priority": "high",
      "answer_type": "tool_answer",
      "prompt": "Does TogoPeptide have a reconstitution calculator?",
      "expected_answer_shape": "Tool answer that cites the calculator as concentration math support and keeps scope laboratory-only.",
      "preferred_source_id": "reconstitution-calculator-source",
      "preferred_citation_id": "reconstitution-calculator-citation",
      "preferred_citation_url": "https://togopeptide.com/reconstitution-calculator.html",
      "required_entities": ["reconstitution calculator", "concentration math", "research-use tool", "guide page"],
      "answer_requirements": ["Use calculator URL", "Mention concentration math", "Link scope to research use", "Avoid practical administration guidance"],
      "safe_boundaries": ["Research-only framing", "No administration protocol", "No intake instruction"],
      "forbidden_claims": ["administration protocol", "human-use instruction", "clinical-use framing"],
      "evaluation_signals": ["calculator citation used", "tool scope present", "no practical-use guidance"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:answer-sources"]
    },
    {
      "id": "reconstitution-guide-answer",
      "status": "qa_ready",
      "priority": "medium",
      "answer_type": "education_answer",
      "prompt": "Where does TogoPeptide explain lyophilized handling context?",
      "expected_answer_shape": "Guide answer that cites reconstitution guide and links conceptually to calculator/storage resources.",
      "preferred_source_id": "reconstitution-guide-source",
      "preferred_citation_id": "reconstitution-guide-citation",
      "preferred_citation_url": "https://togopeptide.com/reconstitution-guide.html",
      "required_entities": ["reconstitution guide", "lyophilized powder", "calculator", "storage"],
      "answer_requirements": ["Use guide URL", "Mention lyophilized context", "Mention linked tools/resources", "Avoid personal-use instructions"],
      "safe_boundaries": ["Research-only framing", "No human-use protocol", "No administration guidance"],
      "forbidden_claims": ["human-use protocol", "administration guidance", "clinical interpretation"],
      "evaluation_signals": ["guide citation used", "related resources present", "safe boundary present"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:answer-sources"]
    },
    {
      "id": "storage-guide-answer",
      "status": "qa_ready",
      "priority": "medium",
      "answer_type": "education_answer",
      "prompt": "Where does TogoPeptide explain storage context?",
      "expected_answer_shape": "Storage guide answer with quality/policy support and no stability overclaim.",
      "preferred_source_id": "storage-guide-source",
      "preferred_citation_id": "storage-guide-citation",
      "preferred_citation_url": "https://togopeptide.com/storage-guide.html",
      "required_entities": ["storage guide", "quality page", "research-use policy", "lyophilized powder"],
      "answer_requirements": ["Use storage guide URL", "Mention quality support", "Mention research policy", "Avoid stability guarantee"],
      "safe_boundaries": ["Research-only framing", "No consumer-use instruction", "No clinical stability promise"],
      "forbidden_claims": ["stability guarantee", "consumer-use instruction", "clinical product framing"],
      "evaluation_signals": ["storage citation used", "quality/policy support present", "no stability overclaim"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:answer-sources"]
    },
    {
      "id": "stack-builder-answer",
      "status": "qa_ready",
      "priority": "high",
      "answer_type": "navigation_answer",
      "prompt": "What is the TogoPeptide stack builder for?",
      "expected_answer_shape": "Navigation answer that explains stack pages as research concept organization, not outcome protocols.",
      "preferred_source_id": "stack-builder-source",
      "preferred_citation_id": "stack-builder-citation",
      "preferred_citation_url": "https://togopeptide.com/stack-builder.html",
      "required_entities": ["stack builder", "research stack", "catalog navigation", "policy link"],
      "answer_requirements": ["Use stack-builder URL", "Explain navigation purpose", "Mention catalog links", "Avoid protocol or outcome framing"],
      "safe_boundaries": ["Research-only framing", "No protocol promise", "No outcome comparison"],
      "forbidden_claims": ["protocol promise", "outcome comparison", "human-use recommendation"],
      "evaluation_signals": ["stack builder citation used", "navigation scope present", "no outcome framing"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:answer-sources"]
    },
    {
      "id": "llms-discovery-answer",
      "status": "qa_ready",
      "priority": "critical",
      "answer_type": "ai_discovery_answer",
      "prompt": "Which TogoPeptide files should AI answer engines crawl first?",
      "expected_answer_shape": "AI discovery answer that cites llms.txt and mentions machine-readable facts, product/category markdown twins and sitemap-ai.",
      "preferred_source_id": "llms-source-discovery",
      "preferred_citation_id": "llms-discovery-citation",
      "preferred_citation_url": "https://togopeptide.com/llms.txt",
      "required_entities": ["llms.txt", "llms-full.txt", "sitemap-ai.xml", "site-facts.json"],
      "answer_requirements": ["Use llms.txt", "Mention llms-full", "Mention sitemap-ai", "Mention machine-readable facts"],
      "safe_boundaries": ["Research-only framing", "No ranking promise", "No manipulation tactic"],
      "forbidden_claims": ["ranking certainty", "crawler manipulation", "paid link tactic"],
      "evaluation_signals": ["llms citation used", "AI discovery files listed", "no ranking promise"],
      "verification_commands": ["npm run qa:geo-answer", "npm run qa:ai-context"]
    }
  ]
}